Perrigo third-quarter sales up 13% to $185.3 mil.; soft analgesic sales lead to income drop.
This article was originally published in The Tan Sheet
Executive Summary
PERRIGO THIRD-QUARTER SALES RISE 13% TO $185.3 MIL., boosted by a more than 20% increase in cough/cold products. The over 20% gain was generated by a "stronger end" to the cough and cold season, the company said in a May 9 release. However, net income was down 13.9% to $11.4 mil. in the quarter from $13.3 mil. in the comparable period of fiscal 1994